[1]Bagley,MarkC.;Davis,Terence;Dix,MatthewC.;Rokicki,MichalJ.;Kipling,David[BioorganicandMedicinalChemistryLetters,2007,vol.17,#18,p.5107-5110]
[2]Locationinpatent:experimentalpartBagley,MarkC.;Davis,Terence;Dix,MatthewC.;Fusillo,Vincenzo;Pigeaux,Morgane;Rokicki,MichalJ.;Kipling,David[JournalofOrganicChemistry,2009,vol.74,#21,p.8336-8342]
[3]Duffy,JohnP.;Harrington,EdmundM.;Salituro,FrancescoG.;Cochran,JohnE.;Green,Jeremy;Gao,Huai;Bemis,GuyW.;Evindar,Ghotas;Galullo,VincentP.;Ford,PamellaJ.;Germann,UrsulaA.;Wilson,KeithP.;Bellon,StevenF.;Chen,Guanging;Taslimi,Paul;Jones,Peter;Huang,Cassey;Pazhanisamy;Wang,Yow-Ming;Murcko,MarkA.;Su,MichaelS.S.[ACSMedicinalChemistryLetters,2011,vol.2,#10,p.758-763]
[1]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.5107-5110
Title: Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease.
Journal: The journal of prevention of Alzheimer's disease 20170101
Title: Selective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged Rats.
Journal: Journal of Alzheimer's disease : JAD 20150101
Title: Identification of potent Yes1 kinase inhibitors using a library screening approach.
Journal: Bioorganic & medicinal chemistry letters 20130801
Title: Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4-fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2H)-one (AS1940477), a potent p38 MAP kinase inhibitor.
Journal: Journal of medicinal chemistry 20120913
Title: 1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase.
Journal: Journal of medicinal chemistry 20111124
Title: Comprehensive analysis of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111030
Title: The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor.
Journal: ACS medicinal chemistry letters 20111013
Title: Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2.
Journal: Journal of medicinal chemistry 20110714
Title: Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase.
Journal: Bioorganic & medicinal chemistry letters 20110701
Title: Discovery, synthesis, and investigation of the antitumor activity of novel piperazinylpyrimidine derivatives.
Journal: European journal of medicinal chemistry 20110601
Title: Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
Journal: Chemistry & biology 20101124
Title: Gram-scale synthesis of the p38α MAPK-inhibitor VX-745 for preclinical studies into Werner syndrome.
Journal: Future medicinal chemistry 20100901
Title: Selective p38alpha inhibitors clinically evaluated for the treatment of chronic inflammatory disorders.
Journal: Journal of medicinal chemistry 20100325
Title: Microwave-assisted Ullmann C-S bond formation: synthesis of the P38alpha MAPK clinical candidate VX-745.
Journal: The Journal of organic chemistry 20091106
Title: Inhibition of p38: has the fat lady sung?
Journal: Arthritis and rheumatism 20090201
Title: Synthesis and biological activity of quinolinone and dihydroquinolinone p38 MAP kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20080315
Title: The design and synthesis of novel alpha-ketoamide-based p38 MAP kinase inhibitors.
Journal: Bioorganic & medicinal chemistry letters 20080315
Title: A quantitative analysis of kinase inhibitor selectivity.
Journal: Nature biotechnology 20080101
Title: A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
Journal: Journal of neuroinflammation 20070101
Title: p38 MAP kinase inhibitors. Part 6: 2-arylpyridazin-3-ones as templates for inhibitor design.
Journal: Bioorganic & medicinal chemistry letters 20061115
Title: The development of novel C-2, C-8, and N-9 trisubstituted purines as inhibitors of TNF-alpha production.
Journal: Bioorganic & medicinal chemistry letters 20060815
Title: p38 MAP kinase inhibitors. Part 3: SAR on 3,4-dihydropyrimido[4,5-d]pyrimidin-2-ones and 3,4-dihydropyrido[4,3-d]pyrimidin-2-ones.
Journal: Bioorganic & medicinal chemistry letters 20060815
Title: Small molecular anti-cytokine agents.
Journal: Medicinal research reviews 20060101
Title: A small molecule-kinase interaction map for clinical kinase inhibitors.
Journal: Nature biotechnology 20050301
Title: P38 MAP kinase inhibitors: evolution of imidazole-based and pyrido-pyrimidin-2-one lead classes.
Journal: Current topics in medicinal chemistry 20050101
Title: Synthesis and structure-activity relationship of aminobenzophenones. A novel class of p38 MAP kinase inhibitors with high antiinflammatory activity.
Journal: Journal of medicinal chemistry 20031218
Title: Structural basis for p38alpha MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity.
Journal: Nature structural biology 20030901
Title: Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu.
Journal: Blood 20030115
Title: Duffy JP, et al. The Discovery of VX-745: A Novel and Selective p38α Kinase Inhibitor. ACS Med Chem Lett. 2011 Jul 28;2(10):758-63.
Title: Cicenas J, et al. JNK, p38, ERK, and SGK1 Inhibitors in Cancer. Cancers (Basel). 2017 Dec 21;10(1).
Title: Pradal J, et al. Intra-articular bioactivity of a p38 MAPK inhibitor and development of an extended-release system. Eur J Pharm Biopharm. 2015 Jun;93:110-7.
Title: Alam JJ. Selective Brain-Targeted Antagonism of p38 MAPKα Reduces Hippocampal IL-1β Levels and Improves Morris Water Maze Performance in Aged Rats. J Alzheimers Dis. 2015;48(1):219-27.
Title: Bagley MC, et al. Rapid synthesis of VX-745: p38 MAP kinase inhibition in Werner syndrome cells. Bioorg Med Chem Lett. 2007 Sep 15;17(18):5107-10. Epub 2007 Jul 13.
Title: Hideshima T, et al. Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu. Blood, 2003, 101(2), 703-705.
